Literature DB >> 19576323

Influence of the metabolic syndrome versus the sum of its individual components on left ventricular geometry in young adults (from the Bogalusa Heart Study).

Dharmendrakumar A Patel1, Sathanur R Srinivasan, Wei Chen, Gerald S Berenson.   

Abstract

Current preventive cardiology guidelines strongly recommend identification of metabolic syndrome (MS), a constellation of cardiovascular risk factors, in clinical practice. These MS risk factors, individually or in a cluster, adversely alter left ventricular (LV) geometry. However, it is still unclear whether MS predicts risk, above and beyond its individual risk factors, for abnormal LV geometry. This aspect was examined in 830 asymptomatic patients (mean age 37 years, 69% whites, 41% men) as a part of the Bogalusa Heart Study. Patients with MS (as defined by the National Cholesterol Education Program Adult Treatment Panel III) showed adverse levels of echocardiographic parameters compared with patients without MS. With respect to MS components, patients with eccentric hypertrophy (EH) or concentric hypertrophy (CH) showed higher values of MS risk factors compared with patients with normal geometric pattern but no differences were noted between patients with normal and concentric remodeling. Of note, patients with concentric remodeling versus EH showed significantly higher systolic and diastolic blood pressure and fasting glucose levels. A model including only MS strongly predicted risk of EH (odds ratio [OR] 4.16, p <0.0001) and CH (OR 13.6, p <0.0001) compared with normal LV geometry. In a model including only individual MS risk factors, obesity (EH vs normal OR 14.4, p <0.0001), high blood pressure (CH vs normal OR 19.38, p <0.0001), and high fasting glucose levels (CH vs normal OR 4.02, p = 0.001) were significant predictors of abnormal LV geometry. However, the likelihood ratio test and comparisons of C-statistics for models including only individual MS risk factors versus models also including the MS variable were not significant. In conclusion, MS and its individual risk factors were strongly associated with LV geometry. However, MS did not predict risk of abnormal LV geometry independent of its individual components.

Entities:  

Mesh:

Year:  2009        PMID: 19576323     DOI: 10.1016/j.amjcard.2009.02.063

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

Review 1.  Fatty acid metabolism in pulmonary arterial hypertension: role in right ventricular dysfunction and hypertrophy.

Authors:  Megha Talati; Anna Hemnes
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

2.  Coexistence of obstructive sleep apnoea and metabolic syndrome is independently associated with left ventricular hypertrophy and diastolic dysfunction.

Authors:  Yasuhiro Usui; Yoshifumi Takata; Yuichi Inoue; Katsunori Shimada; Hirofumi Tomiyama; Yosuke Nishihata; Kota Kato; Kazuki Shiina; Akira Yamashina
Journal:  Sleep Breath       Date:  2011-07-21       Impact factor: 2.816

3.  Left Ventricular Structure, Tissue Composition, and Aortic Distensibility in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications.

Authors:  Evrim B Turkbey; Jye-Yu C Backlund; Neville Gai; Marcelo Nacif; Rob J van der Geest; John M Lachin; Anderson Armstrong; Gustavo J Volpe; Saman Nazarian; João A C Lima; David A Bluemke
Journal:  Am J Cardiol       Date:  2022-04-29       Impact factor: 3.133

4.  Gender-specific differences in left ventricular remodelling in obesity: insights from cardiovascular magnetic resonance imaging.

Authors:  Oliver J Rider; Adam Lewandowski; Richard Nethononda; Steffen E Petersen; Jane M Francis; Alex Pitcher; Cameron J Holloway; Sairia Dass; Rajarshi Banerjee; James P Byrne; Paul Leeson; Stefan Neubauer
Journal:  Eur Heart J       Date:  2012-10-10       Impact factor: 29.983

5.  Metabolic syndrome and left ventricular function: is the number of criteria actually important?

Authors:  Marijana Tadic; Branislava Ivanovic; Nada Kostic; Dragan Simic; Danica Matic; Vera Celic
Journal:  Med Sci Monit       Date:  2012-05

6.  The association of left ventricular hypertrophy with metabolic syndrome is dependent on body mass index in hypertensive overweight or obese patients.

Authors:  Federico Guerra; Lucia Mancinelli; Luca Angelini; Marco Fortunati; Alessandro Rappelli; Paolo Dessì-Fulgheri; Riccardo Sarzani
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

7.  Early change of extracellular matrix and diastolic parameters in metabolic syndrome.

Authors:  Angela B S Santos; Mauricio Junges; Daiane Silvello; Adriana Macari; Bruno S de Araújo; Beatriz G Seligman; Bruce B Duncan; Luis Eduardo P Rohde; Nadine Clausell; Murilo Foppa
Journal:  Arq Bras Cardiol       Date:  2013-09-06       Impact factor: 2.000

8.  Association of comorbidity burden with abnormal cardiac mechanics: findings from the HyperGEN study.

Authors:  Senthil Selvaraj; Frank G Aguilar; Eva E Martinez; Lauren Beussink; Kwang-Youn A Kim; Jie Peng; Laura Rasmussen-Torvik; Jin Sha; Marguerite R Irvin; C Charles Gu; Cora E Lewis; Steven C Hunt; Donna K Arnett; Sanjiv J Shah
Journal:  J Am Heart Assoc       Date:  2014-04-29       Impact factor: 5.501

9.  Frequent cyclic variation of heart rate is associated with left ventricular diastolic dysfunction in patients without ischemia.

Authors:  Takanori Yaegashi; Manabu Nakano; Yoshiharu Murata
Journal:  Health Sci Rep       Date:  2021-12-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.